TPWA
RDY icon

Twin Peaks Wealth Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-557
Closed -$7.71K – 1728
2026
Q1 		$7.71K Buy
+557
New +$7.75K ﹤0.01% 1193
2025
Q3 		– Sell
-621
Closed -$8.64K – 1644
2025
Q2 		$8.64K Buy
+621
New +$8.87K ﹤0.01% 1019

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Twin Peaks Wealth Advisors's RDY Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 557 shares — an estimated $7.71K sold.

Twin Peaks Wealth Advisors first reported a position in RDY in Q2 2025 and held it in 2 quarters. The position peaked at $8.64K in Q2 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 557 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $7.71K.
  • Twin Peaks Wealth Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2025 and held it in 2 quarters.
  • Twin Peaks Wealth Advisors's Dr. Reddy's Laboratories position peaked at $8.64K in Q2 2025.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.